KA
Therapeutic Areas
Kringle Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| KP-100IT (HGF protein) | Acute Spinal Cord Injury | Phase 3 |
| HGF protein | Amyotrophic Lateral Sclerosis (ALS) | Phase 2 |
| Drug | Indication | Phase |
|---|---|---|
| KP-100IT (HGF protein) | Acute Spinal Cord Injury | Phase 3 |
| HGF protein | Amyotrophic Lateral Sclerosis (ALS) | Phase 2 |